However, in our cohort of patients, SARS-CoV-2 VL in the lungs ranged from 0 to 250,281 copies of SARS-CoV-2 cDNA per 100 copies of ABL1, and no association was found between SARS-CoV-2 VL in the lungs and fatal outcome of COVID-19. This evidence concerns the gene ABL1 and COVID-19.